Medusa achieves FDA 510(k)
20:19 26 January
in Siren ePCR Suite
Medusa Medical is pleased to announce that it has achieved FDA 510(k) premarket notification clearance (K131272) from the US Food and Drug Administration for Siren ePCR Suite.
No Comments